反応式
[CH:1]1([CH2:6][C:7]([OH:9])=O)[CH2:5][CH2:4][CH2:3][CH2:2]1.Cl.[NH2:11][C@H:12]([C:14]([NH:16][CH:17]1[C:23](=[O:24])[N:22]([CH2:25][CH:26]([CH3:28])[CH3:27])[C:21]2[CH:29]=[CH:30][CH:31]=[CH:32][C:20]=2[N:19]([CH2:33][CH:34]([CH3:36])[CH3:35])[C:18]1=[O:37])=[O:15])[CH3:13]>>[CH:1]1([CH2:6][C:7]([NH:11][C@H:12]([C:14]([NH:16][CH:17]2[C:18](=[O:37])[N:19]([CH2:33][CH:34]([CH3:35])[CH3:36])[C:20]3[CH:32]=[CH:31][CH:30]=[CH:29][C:21]=3[N:22]([CH2:25][CH:26]([CH3:28])[CH3:27])[C:23]2=[O:24])=[O:15])[CH3:13])=[O:9])[CH2:2][CH2:3][CH2:4][CH2:5]1参加物
3
実験手順
Following General Procedure I above using cyclopentylacetic acid (Aldrich) and 3-(L-alaninyl)amino-2,4-dioxo-1,5-bis-(2-methylpropyl)-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine hydrochloride (Example 8-S), the title compound was prepared as an amorphous white solid. Purification was by flash chromatography eluting with CH2Cl2/EtOAc (1:1). Rf=0.31 (CH2Cl2/EtOAc, 1:1).
後処理
- customPurification
- washeluting with CH2Cl2/EtOAc (1:1)
出典と根拠
- ORDレコード
- ord-0d2e17e035a442e3b782a97bfd224756
- 出典データセット
- uspto-grants-2006_12
- 特許番号
- US07153847B2
関連ノート
読み込み中…